Hepatic Expression of ABC Transporters G5 and G8 Does Not Correlate With Biliary Cholesterol Secretion in Liver Transplant Patients *
Open Access
- 25 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 42 (5) , 1166-1174
- https://doi.org/10.1002/hep.20886
Abstract
: The adenosine triphosphate (ATP)-binding cassette (ABC)-transporters ABCG5 and ABCG8 have been shown to mediate hepatic and intestinal excretion of cholesterol. In various (genetically modified) murine models, a strong relationship was found between hepatic expression of ABCG5/ABCG8 and biliary cholesterol content. Our study aimed to relate levels of hepatic expression of ABCG5 and ABCG8 to biliary excretion of cholesterol in man. From 24 patients who had received a liver transplant, bile samples were collected daily after transplantation over a 2-week period to determine biliary composition. Expression of ABCG5, ABCG8, MDR3, and BSEP was assessed by real-time polymerase chain reaction (PCR) in liver biopsy specimens collected before and after transplantation. Levels of hepatic ABCG5, ABCG8, and MDR3 messenger RNA (mRNA) were strongly correlated. After transplantation, the biliary secretion rate of cholesterol continuously increased, coinciding with gradual increases in bile salt and phospholipid secretion. In contrast, hepatic levels of ABCG5 and ABCG8 mRNA remained unchanged. Surprisingly, no correlation was found between the hepatic expression of ABCG5 and ABCG8 and rates of biliary cholesterol secretion, normalized for biliary phospholipid secretion. As expected, the concentration of biliary phospholipids correlated well with MDR3 expression. In conclusion , the strong relationship between ABCG5 and ABCG8 gene expression is consistent with the coordinate regulation of both genes, and in line with heterodimerization of both proteins into a functional transporter. Hepatic ABCG5/ABCG8 expression, at least during the early phase after transplantation, is not directly related to biliary cholesterol secretion in humans. This finding suggests the existence of alternative pathways for the hepatobiliary transport of cholesterol that are not controlled by ABCG5/ABCG8. (Hepatology 2005;42:1166–1174.)Keywords
This publication has 47 references indexed in Scilit:
- The ins and outs of reverse cholesterol transportAnnals of Medicine, 2004
- Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretionProceedings of the National Academy of Sciences, 2002
- Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterolJournal of Clinical Investigation, 2002
- Control of Cholesterol Turnover in the MouseJournal of Biological Chemistry, 2002
- Two Genes That Map to the STSL Locus Cause Sitosterolemia: Genomic Structure and Spectrum of Mutations Involving Sterolin-1 and Sterolin-2, Encoded by ABCG5 and ABCG8, RespectivelyAmerican Journal of Human Genetics, 2001
- Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorptionNature Genetics, 2001
- Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC TransportersScience, 2000
- Mechanisms and (Patho)Physiological Significance of Biliary Cholesterol SecretionPublished by Springer Nature ,1997
- β-Sitosterolemia and XanthomatosisNew England Journal of Medicine, 1976
- β-Sitosterolemia and XanthomatosisJournal of Clinical Investigation, 1974